{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T14:55:18Z","timestamp":1772808918976,"version":"3.50.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2010,10,1]],"date-time":"2010-10-01T00:00:00Z","timestamp":1285891200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2011,1]]},"DOI":"10.1007\/s10067-010-1579-z","type":"journal-article","created":{"date-parts":[[2010,9,30]],"date-time":"2010-09-30T06:12:45Z","timestamp":1285827165000},"page":"139-144","source":"Crossref","is-referenced-by-count":5,"title":["Active Paget\u2019s disease of bone with normal biomarkers of bone metabolism: a case report and review of the literature"],"prefix":"10.1007","volume":"30","author":[{"given":"Lamprini","family":"Gkouva","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Andrikoula","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vasilis","family":"Kontogeorgakos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dionysios J.","family":"Papachristou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agathocles","family":"Tsatsoulis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,10,1]]},"reference":[{"key":"1579_CR1","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1177\/095952877706000105","volume":"60","author":"J Paget","year":"1877","unstructured":"Paget J (1877) On a form of chronic inflammation of bones. Trans Med Chir Soc Lond 60:37\u201363","journal-title":"Trans Med Chir Soc Lond"},{"key":"1579_CR2","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1359\/jbmr.2001.16.8.1379","volume":"16","author":"ES Siris","year":"2001","unstructured":"Siris ES, Lyles KW, Singer FR, Meunier PJ (2001) A clinical approach to diagnosis and management of Paget\u2019s disease of bone. J Bone Miner Res 16:1379\u20131387","journal-title":"J Bone Miner Res"},{"key":"1579_CR3","volume-title":"Pathophysiology and treatment of Paget\u2019s disease of bone","author":"J Kanis","year":"1998","unstructured":"Kanis J (1998) Pathophysiology and treatment of Paget\u2019s disease of bone, 2nd edn. Martin Dunitz, London","edition":"2"},{"key":"1579_CR4","first-page":"985","volume-title":"Disorders of bone and mineral metabolism","author":"R Altman","year":"2002","unstructured":"Altman R (2002) Paget\u2019s disease of bone. In: Coe FL, Favus MJ (eds) Disorders of bone and mineral metabolism, 2nd edn. Lippincott Williams & Wilkins, Philadelphia, pp 985\u20131020","edition":"2"},{"key":"1579_CR5","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/S8756-3282(02)00876-1","volume":"31","author":"T Doyle","year":"2002","unstructured":"Doyle T, Gunn J, Anderson G, Gill M, Cundy T (2002) Paget\u2019s disease in New Zealand: evidence for declining prevalence. Bone 31:616\u2013619","journal-title":"Bone"},{"key":"1579_CR6","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1359\/jbmr.2002.17.3.465","volume":"17","author":"TP Staa Van","year":"2002","unstructured":"Van Staa TP, Selby P, Leufkens HG, Lyles K, Sprafka JM, Cooper C (2002) Incidence and natural history of Paget\u2019s disease of bone in England and Wales. J Bone Miner Res 17:465\u2013471","journal-title":"J Bone Miner Res"},{"issue":"5 Suppl","key":"1579_CR7","doi-asserted-by":"crossref","first-page":"3S","DOI":"10.1016\/S8756-3282(99)00023-X","volume":"24","author":"C Cooper","year":"1999","unstructured":"Cooper C, Dennison E, Schafheutle K, Kellingray S, Guyer P, Barker D (1999) Epidemiology of Paget\u2019s disease of bone. Bone 24(5 Suppl):3S\u20135S","journal-title":"Bone"},{"key":"1579_CR8","first-page":"409","volume-title":"Primer on the metabolic bone diseases and disorders of mineral metabolism","author":"ES Siris","year":"1996","unstructured":"Siris ES (1996) Paget\u2019s disease of bone. In: Favus MJ (ed) Primer on the metabolic bone diseases and disorders of mineral metabolism, 3rd edn. Lippincott-Raven, Philadelphia, pp 409\u2013419","edition":"3"},{"key":"1579_CR9","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1016\/S0149-2918(97)80007-0","volume":"19","author":"RD Tiegs","year":"1997","unstructured":"Tiegs RD (1997) Paget\u2019s disease of bone: indications for treatment and goals of therapy. Clin Ther 19:1309\u20131329","journal-title":"Clin Ther"},{"issue":"5 Suppl","key":"1579_CR10","doi-asserted-by":"crossref","first-page":"11S","DOI":"10.1016\/S8756-3282(99)00027-7","volume":"24","author":"M Davie","year":"1999","unstructured":"Davie M, Davies M, Francis R, Fraser W, Hosking D, Transley R (1999) Paget\u2019s disease of bone: a review of 889 patients. Bone 24(5 Suppl):11S\u201312S","journal-title":"Bone"},{"key":"1579_CR11","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.2106\/00004623-199173090-00013","volume":"73","author":"A Hadjipavlou","year":"1991","unstructured":"Hadjipavlou A, Lander P (1991) Paget\u2019s disease of the spine. J Bone Joint Surg Am 73:1376\u20131381","journal-title":"J Bone Joint Surg Am"},{"key":"1579_CR12","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1093\/oxfordjournals.bmb.a072011","volume":"40","author":"DJ Barker","year":"1984","unstructured":"Barker DJ (1984) The epidemiology of Paget\u2019s disease of bone. Br Med Bull 40:396\u2013400","journal-title":"Br Med Bull"},{"issue":"5 Suppl","key":"1579_CR13","doi-asserted-by":"crossref","first-page":"19S","DOI":"10.1016\/S8756-3282(99)00033-2","volume":"24","author":"AP Mee","year":"1999","unstructured":"Mee AP (1999) Paramyxoviruses and Paget\u2019s disease: the affirmative view. Bone 24(5 Suppl):19S\u201321S","journal-title":"Bone"},{"key":"1579_CR14","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1006\/mgme.2001.3256","volume":"74","author":"MJ Kovach","year":"2001","unstructured":"Kovach MJ, Waggoner B, Leal SM, Gelber D, Khardori R, Lenenstien MA, Shanks CA, Gregg G, Al-Lozi MT, Miller T, Rakowicz W, Lopate G, Florence J, Glosser G, Simmons Z, Morris JC, Whyte MP, Pestronk A, Kimonis VE (2001) Clinical delineation and localization to chromosome 9p13.3-p12 of a unique dominant disorder in four families: hereditary inclusion body myopathy, Paget disease of bone and frontotemporal dementia. Mol Genet Metab 74:458\u2013475","journal-title":"Mol Genet Metab"},{"key":"1579_CR15","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/S8756-3282(00)00278-7","volume":"26","author":"L Hocking","year":"2000","unstructured":"Hocking L, Slee F, Haslam SI, Cundy T, Nicholson G, van Hul W, Ralston SH (2000) Familial Paget\u2019s disease of bone: patterns of inheritance and frequency of linkage to chromosome 18 q. Bone 26:577\u2013580","journal-title":"Bone"},{"key":"1579_CR16","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1056\/NEJMcp060278","volume":"355","author":"MP Whyte","year":"2006","unstructured":"Whyte MP (2006) Paget\u2019s disease of bone. NEJM 355:593\u2013600","journal-title":"NEJM"},{"key":"1579_CR17","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1359\/jbmr.2000.15.12.2315","volume":"15","author":"MH Helfrich","year":"2000","unstructured":"Helfrich MH, Hobson RP, Grabowski PS et al (2000) A negative search for a paramyxoviral etiology of Paget\u2019s disease of bone: molecular, immunological, and ultrastructural studies in UK patients. J Bone Miner Res 15:2315\u20132329","journal-title":"J Bone Miner Res"},{"key":"1579_CR18","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1148\/radiographics.22.5.g02se281191","volume":"22","author":"SE Smith","year":"2002","unstructured":"Smith SE, Murphey MD, Motamedi K, Mulligan ME, Resnik CS, Gannon FH (2002) Radiologic spectrum of Paget disease of bone and its complications with pathologic correlation. Radiographics 22:1191\u20131216","journal-title":"Radiographics"},{"issue":"2","key":"1579_CR19","first-page":"74","volume":"2","author":"A Singh","year":"2006","unstructured":"Singh A, Rana K (2006) Paget\u2019s disease with an unusual presentation: case report. Journal of the Indian Academy of Geriatrics 2(2):74\u201377","journal-title":"Journal of the Indian Academy of Geriatrics"},{"key":"1579_CR20","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1002\/jbmr.5650100318","volume":"10","author":"L Alvarez","year":"1995","unstructured":"Alvarez L, Guanabens N, Penis P, Monegal A, Bedini JL, Deulofeu R, Martinez de Osaba MJ, Rivera-Fillat F, Ballesta AM (1995) Discriminative value of biochemical markers of bone turnover in assessing the activity of Paget\u2019s disease. J Bone Miner Res 10:458\u2013465","journal-title":"J Bone Miner Res"},{"key":"1579_CR21","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/S8756-3282(02)00817-7","volume":"31","author":"PL Selby","year":"2002","unstructured":"Selby PL, Davie MWJ, Ralston H et al (2002) Guidelines on the management of Paget\u2019s disease of bone. Bone 31:10\u201319","journal-title":"Bone"},{"issue":"Suppl2","key":"1579_CR22","doi-asserted-by":"crossref","first-page":"P22","DOI":"10.1359\/jbmr.06s204","volume":"21","author":"S Shankar","year":"2006","unstructured":"Shankar S, Hosking DJ (2006) Biochemical assessment of Paget\u2019s disease of bone. J Bone Miner Res 21(Suppl2):P22\u2013P27","journal-title":"J Bone Miner Res"},{"key":"1579_CR23","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s002239900336","volume":"61","author":"L Sinigaglia","year":"1997","unstructured":"Sinigaglia L, Varenna M, Binelli L, Beltrametti P, Yucchi F, Arrigoni M, Frignani S, Abbiati G (1997) Serum levels of pyridinium crosslinks in postmenopausal women and in Paget\u2019s disease of bone. Calcif Tissue Int 61:279\u2013284","journal-title":"Calcif Tissue Int"},{"key":"1579_CR24","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0169-6009(91)90143-N","volume":"8","author":"D Uebelhart","year":"1990","unstructured":"Uebelhart D, Gineyts E, Chapuy M, Delmas PD (1990) Urinary excretion of pyridinium crosslinks: anew marker of bone resorption in metabolic bone disease. Bone Miner 8:87\u201396","journal-title":"Bone Miner"},{"key":"1579_CR25","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/0221-8747(81)90040-0","volume":"3","author":"I Fogelman","year":"1981","unstructured":"Fogelman I, Carr D, Boyle IT (1981) The role of bone scanning in Paget\u2019s disease. Metab Bone Dis Relat Res 3:243\u2013254","journal-title":"Metab Bone Dis Relat Res"},{"issue":"5 Suppl","key":"1579_CR26","doi-asserted-by":"crossref","first-page":"1S","DOI":"10.1016\/S8756-3282(99)00022-8","volume":"24","author":"R Smith","year":"1999","unstructured":"Smith R (1999) Paget\u2019s disease of bone: past and present. Bone 24(5 Suppl):1S\u20132S","journal-title":"Bone"},{"issue":"5","key":"1579_CR27","first-page":"913","volume":"3","author":"M Seton","year":"2007","unstructured":"Seton M, Krane S (2007) Use of zoledronic acid in the treatment of Paget\u2019s disease. Ther Clin Risk Manag 3(5):913\u2013918","journal-title":"Ther Clin Risk Manag"},{"key":"1579_CR28","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/bcr414","volume":"4","author":"H Fleisch","year":"2002","unstructured":"Fleisch H (2002) Development of biphosphonates. Breast Cancer Res 4:30\u201334","journal-title":"Breast Cancer Res"},{"issue":"2 Suppl 2","key":"1579_CR29","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.bone.2005.11.011","volume":"38","author":"D Hosking","year":"2006","unstructured":"Hosking D (2006) Pharmacological therapy of Paget\u2019s and other metabolic bone diseases. Bone 38(2 Suppl 2):S3\u2013S7","journal-title":"Bone"},{"key":"1579_CR30","doi-asserted-by":"crossref","first-page":"3721","DOI":"10.1021\/jm020819i","volume":"45","author":"L Widler","year":"2002","unstructured":"Widler L, Jaeggi KA, Glatt M et al (2002) Highly potent geminal biphosphonates. From pamidronate disodium (Aredia) to zoledronic acid (Zometa). J Med Chem 45:3721\u20133738","journal-title":"J Med Chem"},{"key":"1579_CR31","doi-asserted-by":"crossref","first-page":"81S","DOI":"10.1016\/S8756-3282(99)00071-X","volume":"24","author":"H Buckler","year":"1999","unstructured":"Buckler H, Fraser W, Hosking D et al (1999) Single infusion of zoledronate in Paget\u2019s disease of bone: a placebo-controlled, dose-ranging study. Bone 24:81S\u201385S","journal-title":"Bone"},{"key":"1579_CR32","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1136\/ard.62.3.275","volume":"62","author":"G Chung","year":"2003","unstructured":"Chung G, Keen RW (2003) Zoledronate treatment in active Paget\u2019s disease. Ann Rheum Dis 62:275\u2013276","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"1579_CR33","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1359\/jbmr.061001","volume":"22","author":"D Hosking","year":"2007","unstructured":"Hosking D, Lyles K, Brown JP, Fraser WD, Miller P, Curiel MD, Devogelaer JP, Hooper M, Su G, Zelenakas K, Pak J, Fashola T, Saidi Y, Eriksen EF, Reid IR (2007) Long-term control of bone turnover in Paget's disease with zoledronic acid and risedronate. J Bone Miner Res 22(1):142\u2013148","journal-title":"J Bone Miner Res"},{"issue":"1","key":"1579_CR34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00223-006-0184-2","volume":"80","author":"AL Langston","year":"2007","unstructured":"Langston AL, Campbell MK, Fraser WD, Maclennan G, Selby P, Ralston SH (2007) Clinical determinants of quality of life in Paget\u2019s disease of bone. Calcif Tissue Int 80(1):1\u20139","journal-title":"Calcif Tissue Int"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-010-1579-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-010-1579-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-010-1579-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T08:51:44Z","timestamp":1559119904000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-010-1579-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10,1]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,1]]}},"alternative-id":["1579"],"URL":"https:\/\/doi.org\/10.1007\/s10067-010-1579-z","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,10,1]]}}}